Belluscura PLC
LSE:BELL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Goertek Inc
SZSE:002241
|
CN |
|
G
|
Glacier Bancorp Inc
NYSE:GBCI
|
US |
Belluscura PLC
Total Equity
Belluscura PLC
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Belluscura PLC
LSE:BELL
|
Total Equity
$20.4m
|
CAGR 3-Years
63%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Total Equity
$5.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Total Equity
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
16%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Total Equity
£69.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Total Equity
£42.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Total Equity
£16.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
22%
|
|
Belluscura PLC
Glance View
Belluscura Plc engages in the provision of medical devices. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The firm is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.
See Also
What is Belluscura PLC's Total Equity?
Total Equity
20.4m
USD
Based on the financial report for Dec 31, 2023, Belluscura PLC's Total Equity amounts to 20.4m USD.
What is Belluscura PLC's Total Equity growth rate?
Total Equity CAGR 5Y
55%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Belluscura PLC have been 63% over the past three years , 55% over the past five years .
